Skip to main content
Figure 2 | Journal of Translational Medicine

Figure 2

From: Blockade of phospholipid scramblase 1 with its N-terminal domain antibody reduces tumorigenesis of colorectal carcinomas in vitro and in vivo

Figure 2

Anti-PLSCR1 represses the proliferation of CRC cells in vitro . (A) The proliferation of HT29 cells was inhibited by treatment with NP1 in a dose-dependent manner. Error bars show the SD. * p < 0.05. (B) Growth curves of CRC cells (HT29, HCT15, HCT116, WiDr, LoVo, CoLo205, SW620, HepG2 and WI-38) treated with isotope-control IgG, NP1, or NP1 previously neutralized with recombinant PLSCR1 are shown.

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us